期刊文献+

实时心肌超声造影评价肥厚型心肌病心肌灌注的研究 被引量:1

Evaluation of myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy by myocardial contrast echocardiography
原文传递
导出
摘要 目的应用实时心肌超声造影研究肥厚型心肌病(HCM)患者心肌灌注状况,评价HCM患者心肌微循环障碍。方法HCM患者20例,正常对照组20例,经肘静脉注射Sono Vue行实时心肌超声造影。取闪烁前5个心动周期及闪烁后15个心动周期的心尖四腔、心尖两腔、左心长轴观实时动态图像传输到EchoPAC工作站。启动Q-analysis软件,应用时间-强度曲线分析造影图像。结果HCM患者左室肥厚节段闪烁后造影平台强度(A)、信号强度增加速率(k)及A×k值与正常人心室肌相应节段测值差异有统计学意义(分别P=0.01,P〈0.001,P<0.036)。HCM患者左室非肥厚节段A、k及A×k值与正常人心室肌相应节段测值差异有统计学意义(均P〈0.001)。HCM患者左室肥厚节段A、k、A×k值与HCM非肥厚心肌节段测值差异有统计学意义(P=0.021,P=0.016,P=0.001)。相应的标化值:HCM患者左室肥厚节段A/A。,(A×k)/(Ao×ko)值明显低于正常人心室肌相应节段(分别P=0.031,P〈0.001),HCM患者左室非肥厚节段A/Ao及(A×k)/(Ao×ko)值明显低于正常人心室肌相应节段(分别P=0.002,P〈0.001),HCM患者左室肥厚节段A/Ao及(A×k)/(Ao×ko)值低于HCM患者非肥厚心肌节段(分别P=0.045,P=0.021)。结论实时心肌超声造影是评价HCM患者心肌微循环障碍的有效方法。 Objective To evaluate the microcirculation abnormalities in the patients with hypertrophic cardiomyopathy(HCM). Methods Twenty patients with HCM and 20 healthy volunteers were included in the study. Two dimensional images on the apical four-chamber, two chamber and long-axis views,including 5 cardiac cycles before ‘flash’ and 15 cardiac cycles after ‘flash', were recorded and stored for off-line analysis in EchoPAC workstation. Then,contrast time intensity curves were obtained for each available left ventricular segment. Results There were significant differences in the A,k and the product A × k between the hypertrophic wall segments ( P = 0.01 , P 〈0. 001, P = 0. 036, respectively) and nonhypertrophic wall segments ( P 〈0. 001,respectively) and healthy subjects. A,k and the product A × k in hypertrophic wall segments were significantly different from those in nonhypertrophic wall segments in patients with HCM ( P = 0. 021, P = 0. 016, P = 0. 001 ,respectively). Accordingly,the normalized value of A and the product A × k were lower in hypertrophied wall segments (P = 0. 031, P 〈 0. 001, respectively) and nonhypertrophied wall segments( P = 0. 002, P 〈0. 001 ,respectively) in patients with HCM than those in normal segments of healthy controls. The normalized value of A and the product A ~ k were lower in hypertrophic wall segments than nonhypertrophic wall segments in patients with HCM( P = 0. 045, P = 0. 021 ,respectively). Conclusions Myocardial contrast echocardiography is a useful method to investigate myocardial perfusion abnormalities in patients with HCM.
出处 《中华超声影像学杂志》 CSCD 北大核心 2009年第5期385-388,共4页 Chinese Journal of Ultrasonography
关键词 肥厚型心肌病 超声造影评价 心肌灌注 心肌微循环障碍 心肌超声造影 心肌节段 左室肥厚 信号强度 Echocardiography Microbubbles Cardiomyopathy, hypertrophic Coronary circulation
  • 相关文献

参考文献13

  • 1刘文玲,胡大一.肥厚型心肌病的分子遗传学诊断与危险分层[J].中国心脏起搏与心电生理杂志,2004,18(5):388-389. 被引量:3
  • 2Cecchi F,Olivotto I,Gistri R,et al.Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.N Engl J Med,2003,349:1027-1035.
  • 3Petersen SE,Jerosch-Herold M,Hudsmith LE,et al.Evidence for microvascular dysfunction in hypertrophic cardiomyopathy:new insights from multiparametric magnetic resonance imaging.Circulation,2007,115:2418-2425.
  • 4Malm S,Frigstad S,Helland F,et al.Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography.A feasibility study.Cardiovasc Ultrasound,2005,16:3-16.
  • 5Maron BJ,Mckenna WJ,Danielson GK.American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy.A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.J Am Coll Cardiol,2003,42:1687-1713.
  • 6黎鹏,邓又斌,杨好意,王红英,魏翔,张清阳,毕小军,申屠伟慧,黎春蕾,白姣.实时心肌超声造影评价冠状动脉搭桥术前后心肌灌注[J].中华超声影像学杂志,2007,16(4):294-297. 被引量:10
  • 7Ghanem A,DeMaria AN,Lohmaier S,et al.Triggered replenishment imaging reduces variability of quantitative myocardial contrast echocardiography and allows assessment of myocardial blood flow reserve.Echocardiography,2007,24:149-158.
  • 8Camici P,Chiriatti G,Lorenzoni R,et al.Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myoeardium of patients with hypertrophic cardiomyopathy:a study with nitrogen-13 ammonia and positron emission tomography.J Am Coll Cardiol,1991,17:879-886.
  • 9Kofflard MJ,Michels M,Krams R,et al.Coronary flow reserve in hypertrophic cardiomyopathy:relation with microvascular dysfunction and pathophysiological characteristics.Neth Heart J,2007,15:209-215.
  • 10Johansson B,Morner S,Waldenstrom A,et al.Myocardial capillary supply is limited in hypertrophic cardiomyopathy:A morphological analysis.Int J Cardiol,2008,126:252-257.

二级参考文献24

  • 1舒先红,潘翠珍,郭士遵,董丽莉,阮雯,李延林,葛均波,陈灏珠.多巴酚丁胺负荷超声和实时声学造影评价介入治疗术后心肌灌注[J].中华超声影像学杂志,2005,14(6):428-432. 被引量:3
  • 2邓又斌 王新房 王加恩.双氧水心肌灌注声学造影法的实验研究[J].中华物理医学杂志,1987,9:217-219.
  • 3Maron BJ,Estes NA,Maron MS,et al.Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy[J].Circulation,2003,107:2 872
  • 4Maron BJ,Moller JH,Seidman CE,et al.Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:Hypertrophic cardiomyopathy,long-QT syndrome,and Marfan syndrome[J].Circulation,1998,98:1 460
  • 5Schwartz K,Carrier L,Guicheney P,et al.Molecular basis of familial cardiomyopathies[J].Circulation,1995,91:532
  • 6Niimura H,Bachinski LL,Sangwatanaroj S,et al.Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy[J].N EngI J Med,1998,338:1 248
  • 7Osterop AP,Kofflard MJ,Sandkuijl LA,et al.AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy[J].Hypertension,1998,32:825
  • 8Lechin M,Quinones MA,Omran A,et al.Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy[J].Circulation,1995,92:1 808
  • 9Hagege AA,Dubourg O,Desnos M,et al.Familial hypertrophic cardiomyopathy.Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy[J].Eur Heart J,1998,19:490
  • 10Maron BJ,Shen W-K,Link MS,et al.Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy[J].N Engl J Med,2000,342:365

共引文献11

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部